Abklärung erhöhter Aminotransferasen (ALT und AST) im Kindesalter

Die Leber ist ein einzigartiges Organ, das von der V. portae und der A. hepatica versorgt wird. Daraus ergeben sich Besonderheiten, die unterschiedlichen Einfluss auf einen möglichen Leberschaden nehmen. Erhöhte „Transaminasen“ müssen dementsprechend im klinischen Kontext interpretiert werden. Dieser Beitrag soll hierfür eine Hilfestellung leisten, Muster frühzeitig zu erkennen und dringlich zu behandelnden Erkrankungen schnell entgegenzuwirken.

Schlüsselwörter

AST - ALT - Hepatopathie - Cholestase - Kinder

• Literatur

• 1 Squires JE, Alonso EM, Ibrahim SH. et al. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Diagnosis and Management of Pediatric Acute Liver Failure. J Pediatr Gastroenterol Nutr 2022; 74: 138-158
• 2 Berardi G, Guglielmo N, Colasanti M. et al. Differential Diagnosis of Acute Liver Failure in Children: A Systematic Review. Pediatr Gastroenterol Hepatol Nutr 2020; 23: 501-510
• 3 Alonso EM, Horslen SP, Behrens EM. et al. Pediatric acute liver failure of undetermined cause: A research workshop. Hepatology 2017; 65: 1026-1037
• 4 Lutfi R, Abulebda K, Nitu ME. et al. Intensive Care Management of Pediatric Acute Liver Failure. J Pediatr Gastroenterol Nutr 2017; 64: 660-670
• 5 Madadi-Sanjani O, Blaser J, Voigt G. et al. Home-based color card screening for biliary atresia: the first steps for implementation of a nationwide newborn screening in Germany. Pediatr Surg Int 2019; 35: 1217-1222
• 6 Shaw JL, Cohen A, Konforte D. et al. Validity of establishing pediatric reference intervals based on hospital patient data: a comparison of the modified Hoffmann approach to CALIPER reference intervals obtained in healthy children. Clin Biochem 2014; 47: 166-172
• 7 Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ 2005; 172: 367-379
• 8 Schmidt LE, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology 2002; 36: 659-665
• 9 Fawaz R, Baumann U, Ekong U. et al. Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2017; 64: 154-168
• 10 Tripath N, Jialal I. Conjugated Hyperbilirubinemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing LLC; 2021
• 11 Sundaram SS, Bove KE, Lovell MA. et al. Mechanisms of disease: Inborn errors of bile acid synthesis. Nat Clin Pract Gastroenterol Hepatol 2008; 5: 456-468
• 12 Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Blood 2020; 135: 1332-1343
• 13 Jain V, Dhawan A. Prognostic modeling in pediatric acute liver failure. Liver Transpl 2016; 22: 1418-1430
• 14 Chang CH, Bryce CL, Shneider BL. et al. Accuracy of the Pediatric End-stage Liver Disease Score in Estimating Pretransplant Mortality Among Pediatric Liver Transplant Candidates. JAMA Pediatr 2018; 172: 1070-1077
• 15 Bolia R, Srivastava A, Yachha SK. et al. Pediatric CLIF-SOFA score is the best predictor of 28-day mortality in children with decompensated chronic liver disease. J Hepatol 2018; 68: 449-455
• 16 Socha P, Janczyk W, Dhawan A. et al. Wilson’s Disease in Children: A Position Paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018; 66: 334-344
• 17 Hayashi PH. Overview of causality assessment in drug-induced liver injury. Clin Liver Dis (Hoboken) 2017; 9: 29-33
• 18 Mieli-Vergani G, Vergani D, Baumann U. et al. Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement. J Pediatr Gastroenterol Nutr 2018; 66: 345-360
• 19 European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015; 63: 237-264
• 20 Shneider BL, Moore J, Kerkar N. et al. Initial assessment of the infant with neonatal cholestasis-Is this biliary atresia?. PLoS One 2017; 12: e0176275
• 21 Shamir SB, Kurian J, Kogan-Liberman D. et al. Hepatic Imaging in Neonates and Young Infants: State of the Art. Radiology 2017; 285: 763-777
• 22 De Gottardi A, Berzigotti A, Buscarini E. et al. Ultrasonography in Liver Vascular Disease. Ultraschall Med 2018; 39: 382-405
• 23 Mjelle AB, Mulabecirovic A, Havre RF. et al. Normal Liver Stiffness Values in Children: A Comparison of Three Different Elastography Methods. J Pediatr Gastroenterol Nutr 2019; 68: 706-712
• 24 Gochanour E, Jayasekera C, Kowdley K. Primary Sclerosing Cholangitis: Epidemiology, Genetics, Diagnosis, and Current Management. Clin Liver Dis (Hoboken) 2020; 15: 125-128
• 25 Lurz E, Patel H, Lebovic G. et al. Paediatric reference values for total psoas muscle area. J Cachexia Sarcopenia Muscle 2020; 11: 405-414
• 26 Deutsche Gesellschaft für Kinderchirurgie e. V.. Weniger Lebertransplantationen bei Neugeborenen durch zentralisierte Gallengangtherapie. Accessed April 02, 2022 at: https://www.dgkch.de/menu-dgkch-home/menu-pressestelle/888-weniger-lebertransplantationen-bei-neugeborenen-durch-zentralisierte-gallengangtherapie
• 27 Dezsőfi A, Baumann U, Dhawan A. et al. Liver biopsy in children: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr 2015; 60: 408-420
• 28 Stalke A, Skawran B, Auber B. et al. Diagnosis of monogenic liver diseases in childhood by next-generation sequencing. Clin Genet 2018; 93: 665-670
• 29 Karpen SJ, Kamath BM, Alexander JJ. et al. Use of a Comprehensive 66-Gene Cholestasis Sequencing Panel in 2171 Cholestatic Infants, Children, and Young Adults. J Pediatr Gastroenterol Nutr 2021; 72: 654-660